Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial.

@article{Krebs2010WormwoodA,
  title={Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial.},
  author={Simone Krebs and Bilal Omer and Talib Noor Omer and Danilo Fliser},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  year={2010},
  volume={56 6},
  pages={1095-9}
}
BACKGROUND Inhibition of the renin-angiotensin system is a widely accepted approach to treat immunoglobulin A (IgA) nephropathy, whereas the role of fish oils as a supplement is controversial. Tumor necrosis factor α (TNF-α) is considered to be involved in the pathophysiologic process of this disorder. Recent in vitro and clinical observations that wormwood can decrease TNF-α levels has led us to investigate the effect of wormwood as a supplement in patients with IgA nephropathy. STUDY DESIGN… CONTINUE READING